Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...

A summary of recent health news includes Louisiana's first bird flu death, WuXi Biologics' sale of an Irish facility to Merck ...

Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...

China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 ...

WuXi Biologics sells its vaccine production facility in Ireland to Merck & Co for $500m in the wake of changing regulation in ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, as oral ...

A new, two-step strategy for making substituted piperidines offers chemists a more efficient way to make these biologically ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as antidotes. But is it safe, and why are they doing so?

More than two years after acquiring Tarus Therapeutics, Portage Biotech is relaunching Tarus’ adenosine receptor antagonists ...